#25-23 Diagonal Bio AB approved for listing at NGM

Report this content

Nordic Growth Market NGM AB (“NGM“) has, as previously announced, decided to list the shares in Diagonal Bio AB at NGM. The first day of trading has been set to March 19, 2025.

 

Information regarding the affected instruments:

 

Listing name: Diagonal Bio

Exchange symbol: DIABIO

ISIN-code: SE0015961826

CFI-code: ESVUFR

FISN-code: DIAGONALBI/SH

Instrument-ID: H5VY

Tick size table/liquidity band: 3

Number of issued shares: 1 214 965 327

First day of trading: 2025-03-19

Market-ID: NSME

Segment-ID: NSSE

 

For more information about this Market Notice, please contact us by e-mail, marketsurveillance@ngm.se or telephone, +46 8 566 390 55.

 

NGM Market Notice Pressroom

https://news.cision.com/ngm-market-notice

Subscribe